Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation

Circulation Journal - Japan
doi 10.1253/circj.cj-14-0720
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Circulation Society

Related search

Healthcare Costs of Stroke and Major Bleeding in Patients With Atrial Fibrillation Treated With Non–vitamin K Antagonist Oral Anticoagulants

Journal of Medical Economics
Health Policy
2019English

Pcv31 - Anticoagulants in Older Patients With Non-Valvular Atrial Fibrillation After Intracranial Hemorrhage

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Overview of the Non-Vitamin K Oral Anticoagulants for Atrial Fibrillation

Therapeutic Advances in Cardiovascular Disease
Cardiovascular MedicinePharmacologyCardiology
2017English

Effectiveness and Safety of Direct Oral Anticoagulants Compared With Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion

Journal of Clinical Trials in Cardiology
2017English

The Comparison of Non-Vitamin K Antagonist Oral Anticoagulants Versus Well-Managed Warfarin With a Lower INR Target of 1.5 to 2.5 in Asians Patients With Non-Valvular Atrial Fibrillation

PLoS ONE
Multidisciplinary
2019English

Patients With Non-Valvular Atrial Fibrillation on Vitamin K Antagonists or Direct-Acting Oral Anticoagulants: Patients Profile and Long-Term Follow-Up Outcomes

Archivos de cardiolog�a de M�xico (English ed. Internet)
2020English

Pharmacological Profile of Non-Vitamin K Antagonist Oral Anticoagulants

African Journal of Pharmacy and Pharmacology
2017English

Effect and Risk of Novel Oral Anticoagulants Versus Warfarin in Patients With Non-Valvular Atrial Fibrillation

Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Discontinuation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Population-Based Cohort Study Using Primary Care Data From the Health Improvement Network in the UK

BMJ Open
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy